Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
about
Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patientsThe role of photopheresis in the treatment of graft-versus-host diseaseChanges in salivary proteome following allogeneic hematopoietic stem cell transplantation.Biomarkers for fatal immune response to stem cell treatment could reduce mortality.Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHDEndpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statementOral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumCurrent issues in chronic graft-versus-host disease.Graft-versus-host disease: state of the science.Eosinophils in the blood of hematopoietic stem cell transplanted patients are activated and have different molecular marker profiles in acute and chronic graft-versus-host diseaseHave we made progress in the management of chronic graft-vs-host disease?Biomarkers in chronic graft-versus-host diseaseThe immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II studyGlobal and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.Treatment of chronic graft-versus-host disease: Past, present and future.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials.Clinical applications for biomarkers of acute and chronic graft-versus-host disease.Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.Progress in chronic graft-versus-host disease.Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group studyBiomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical TrialsStandardizing chronic graft-versus-host disease.Fulminant gastrointestinal graft-versus-host disease concomitant with cytomegalovirus infection: case report and literature reviewOral chronic graft-versus-host disease: current pathogenesis, therapy, and researchChronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.Murine models of chronic graft-versus-host disease: insights and unresolved issues.Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.Study design and endpoints in graft-versus-host disease.Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?High frequency of CD29high intermediate monocytes correlates with the activity of chronic graft-versus-host disease.Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host diseaseBiology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.
P2860
Q26787230-CF3805A4-99B7-4EA3-ADE7-E8FF2A6C57ECQ28280153-6DD3DD55-4FFF-41CE-A6EE-7F08CDB90C8CQ33270568-6A6500AE-D33C-42B1-9B78-2BBEFFAD0FC2Q33563471-2957BFBD-B1C4-44A8-AF7B-690A1B5D3FABQ33591662-6686E8F6-55F0-4721-9B47-C5E29140E56EQ33622648-7F1CCAB7-0F9A-4DAC-8444-40C2F940A556Q33725411-05F33566-FB4E-430B-A037-3A2BBE682A18Q33830644-45E5C7F5-D868-431C-A5CB-1820A0F8BC7BQ33917187-AB28EDF6-3221-41FC-AE13-D14C86A831C3Q33977923-91C7A2E2-1A9C-4856-A464-3136BC9D9F1DQ34442851-2F981169-2BA0-4362-8A1A-EE6DC8777AB5Q34644980-E063D829-D136-4C6B-A434-DD5028952EACQ35094374-B65B2627-B23A-48A9-89A3-9D767CBE43C9Q35193763-A8E1233A-B551-410C-82FF-BA7F95B56F39Q35483810-934E06AA-592B-4C07-B609-880D9E329D8AQ35524687-F8F7B106-2EBC-478B-B5B6-36D6C5A46454Q35533376-3B6D951A-B2E5-4587-9FC5-D03E60C5787FQ35748144-315B75F1-326E-46C9-B81F-A56078D958BCQ35767289-D82A7D3F-720E-474C-9F6B-021044DF48F7Q35784522-1DC4E56B-1ED0-4F21-959C-FD8277076A81Q36153593-FA0A6DF8-AB2D-4C6E-B0FE-F95838610EF3Q36233448-823F3D64-C6D0-450E-A079-BE18A1B2AD5CQ36491894-6D38C348-6F66-4202-A030-24686B56ABD4Q36498345-53B63FBA-0892-4367-B794-75FCF709BC07Q36540762-57565F4C-4570-47C9-8FD6-CE846C229EECQ36572516-112025A4-D50A-43BB-A49F-2ABD8AD5C474Q36572542-B6B391D1-DCAE-4BAD-8F14-DD39E8BAF456Q36579263-7ACB13AF-2BF8-47A3-AD44-87220F18D102Q36596493-DB6EFA33-299A-458C-8DD9-2E7FC25A8594Q36637621-2C6093F1-70FD-40D6-8248-E1B38E32BAE8Q36645730-491B30A4-FA62-4202-B813-6A08B3463A1DQ36707816-795B79B1-6A86-4E10-AE97-E7BA2CB4F7CDQ36747224-628F4F98-2C66-4917-AB0D-DDD4F7055ACCQ36790424-6C752D21-7153-47B0-AF34-A22178972594Q37075990-E982E659-C478-4690-AF8E-DBE15D7BEA76Q37436451-C455E7D0-5A5A-4F49-9823-846898C4F37EQ37479204-3F1C884E-E965-4D4B-938D-3EA9152047AAQ37522548-93B85051-80A7-43C1-B9FA-92BA89210F43Q37626094-0AC80238-3621-4E86-8853-3FB7A376ADB1Q37664888-CAD91621-A49B-401A-B710-A1313428C47A
P2860
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Toward biomarkers for chronic ...... iomarker Working Group Report.
@ast
Toward biomarkers for chronic ...... iomarker Working Group Report.
@en
type
label
Toward biomarkers for chronic ...... iomarker Working Group Report.
@ast
Toward biomarkers for chronic ...... iomarker Working Group Report.
@en
prefLabel
Toward biomarkers for chronic ...... iomarker Working Group Report.
@ast
Toward biomarkers for chronic ...... iomarker Working Group Report.
@en
P2093
P1476
Toward biomarkers for chronic ...... iomarker Working Group Report.
@en
P2093
Alexandra H Filipovich
Barbara Mittleman
Daniel Couriel
Daniel Fowler
Daniel Weisdorf
David B Miklos
Emmanuel Zorn
Ernst Holler
Georgia B Vogelsang
Howard Shulman
P304
P356
10.1016/J.BBMT.2005.11.010
P577
2006-02-01T00:00:00Z